CVE-2022-40246

Public Exploit
Arbitrary write vulnerability in SbPei module leads to arbitrary code execution during PEI phase.

Description

A potential attacker can write one byte by arbitrary address at the time of the PEI phase (only during S3 resume boot mode) and influence the subsequent boot stages. This can lead to the mitigations bypassing, physical memory contents disclosure, discovery of any secrets from any Virtual Machines (VMs) and bypassing memory isolation and confidential computing boundaries. Additionally, an attacker can build a payload which can be injected into the SMRAM memory. This issue affects: Module name: SbPei SHA256: d827182e5f9b7a9ff0b9d3e232f7cfac43b5237e2681e11f005be627a49283a9 Module GUID: c1fbd624-27ea-40d1-aa48-94c3dc5c7e0d

Categories

7.2
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.02%
Vendor Advisory ami.com
Affected: AMI Aptio
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-40246?
CVE-2022-40246 has been scored as a high severity vulnerability.
How to fix CVE-2022-40246?
To fix CVE-2022-40246, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-40246 being actively exploited in the wild?
It is possible that CVE-2022-40246 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-40246?
CVE-2022-40246 affects AMI Aptio.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.